
Purpose: There is currently no consensus on which keratoconus need cross-linking nor on how to establish progression. This study assessed the performance of diverse progression criteria and compared them with our clinical knowledge of keratoconus evolution. Methods: This was a retrospective, longitudinal, observational study. Habitual progression criteria, based on (combinations of) keratometry (KMAX), front astigmatism (AF), pachymetry (PMIN), or ABCD progression display, from 906 keratoconus patients were analyzed. For each criterion and cutoff, we calculated %eyes flagged progressive at some point (RPROG), individual consistency CIND (%examinations after progression detection still considered progressive), and population consistency CPOP (% eyes with CIND >66%). Finally, other monotonic and consistent variables, such as front steep keratometry (K2F), mean radius of the back surface (RmB), and the like, were evaluated for the overall sample and subgroups. Results: Using a single criterion (e.g., ∆KMAX >1D) led to high values of RPROG. When combining two, (KMAX and AF) led to worse CPOP and higher variability than (KMAX and PMIN); alternative criteria such as (K2F and RmB) obtained the best CPOP and the lowest variability (P<0.0001). ABC, as defined by its authors, obtained RPROG of 74.2%. Using wider 95% confidence intervals (95% CIs) and requiring two parameters over 95CI reduced RPROG to 27.9%. Conclusion: Previous clinical studies suggest that 20% to 30% of keratoconus cases are progressive. This clinical RPROG value should be considered when defining KC progression to avoid overtreatment. Using combinations of variables or wider margins for ABC brings RPROG closer to these clinical observations while obtaining better population consistency than current definitions.
Photosensitizing Agents, Photosensitizing Agents/therapeutic use, Ultraviolet Rays, Riboflavin, Visual Acuity, Corneal Topography, Keratoconus/diagnosis, Riboflavin/therapeutic use, Keratoconus, Refraction, Ocular, Cross-Linking Reagents, Photochemotherapy, Collagen/therapeutic use, Humans, Cross-Linking Reagents/therapeutic use, Corneal topography, Human medicine, Collagen, Retrospective Studies
Photosensitizing Agents, Photosensitizing Agents/therapeutic use, Ultraviolet Rays, Riboflavin, Visual Acuity, Corneal Topography, Keratoconus/diagnosis, Riboflavin/therapeutic use, Keratoconus, Refraction, Ocular, Cross-Linking Reagents, Photochemotherapy, Collagen/therapeutic use, Humans, Cross-Linking Reagents/therapeutic use, Corneal topography, Human medicine, Collagen, Retrospective Studies
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
